Close

Morning Movers 08/16: (CCRT) (BTH) (VQ) Higher; (IDIX) (PERY) (NTES) Lower

August 16, 2012 11:28 AM EDT
CompuCredit Holdings Corporation (NASDAQ: CCRT) 36.9% HIGHER; announced Tuesday night that it commenced a cash tender offer for up to 8,250,000 shares of its outstanding common stock, no par value per share, at a purchase price of $10.00 per share.

Idenix Pharmaceuticals Inc. (Nasdaq: IDIX) 28.9% LOWER; announced that hepatitis C drug IDX184 has been placed on partial clinical hold by the FDA due to a serious cardiac-related adverse event. For more color, click here.

Blyth (NYSE: BTH) 18.1% HIGHER; announced that its ViSalius unit filed for an IPO of its common stock. Blyth will still have a majority stake in ViSalius following the IPO, which has a tentative price of $175 million.

Venoco, Inc. (NYSE: VQ) 17.7% HIGHER; announced today that it has been informed by Denver Parent Corporation, an affiliate of Timothy Marquez, Venoco's Executive Chairman, that DPC is engaged in advanced discussions regarding the financing of the merger contemplated by the merger agreement among Venoco, Mr. Marquez, DPC and another affiliate of Mr. Marquez. For more color, click here.

Perry Ellis International, Inc. (NASDAQ: PERY) 16.8% LOWER; reported Q2 EPS of $0.01, $0.02 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $209.4 million versus the consensus estimate of $208.58 million. Sees FY2013 EPS of $1.75-1.80, versus the consensus of $2.01.

Sina Corp (NASDAQ: SINA) 13.7% HIGHER; reported Q2 EPS of $0.05, $0.07 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $131.6 million versus the consensus estimate of $127.26 million. Sees Q3 2012 revenue of $145-148 million, versus the consensus of $147.34 million.

Netease.com (NASDAQ: NTES) 13.0% LOWER; reported Q2 EPS of $1.05, $0.03 worse than the analyst estimate of $1.08. Revenue for the quarter came in at $315.5 million versus the consensus estimate of $333.87 million.

Xueda Education Group (NYSE: XUE) 11.9% HIGHER; reported Q2 EPS of $0.20, $0.05 better than the analyst estimate of $0.15. Revenue for the quarter came in at $96.9 million versus the consensus estimate of $89.79 million. Sees Q3 2012 revenue of $65.7-68.3 million, versus the consensus of $66.50 million. Also sees FY2012 revenue of $283-293 million, versus prior guidance of $272-282 million and the consensus of $282.1 million.

Peregrine Pharmaceuticals, Inc. (PPHM) 10.6% HIGHER; been a momentum mover this week following a positive mention at Roth Capital.

Ascent Solar Technologies, Inc. (Nasdaq: ASTI) 9.1% LOWER; lower as traders take profit after Ascent moved over 60 percent the last week on stronger volume.

Perrigo Co (NASDAQ: PRGO) 8.4% LOWER; reported Q4 EPS of $1.28, $0.02 better than the analyst estimate of $1.26. Revenue for the quarter came in at $831.77 million versus the consensus estimate of $855.8 million. Sees FY2013 EPS of $5.30-5.50, versus the consensus of $5.42.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

Roth Capital, Morning Movers